Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services, LLC is recalling Minocycline HCL capsules because they may have been mislabeled as Minoxidil tablets. The error could lead to patients receiving the wrong medication.
Aidapak Services is recalling dexamethasone tablets that may have been mislabeled as venlafaxine capsules.
Aidapak Services is recalling Efavirenz 200 mg capsules because they may have been mislabeled as metformin HCl 500 mg tablets.
Aidapak Services, LLC is recalling Atorvastatin Calcium 10 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Acarbose 25 mg tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling 0.5 mg tacrolimus capsules because they may have been mislabeled as cinacalcet or isosorbide mononitrate.
Aidapak Services is recalling 16 mg Perphenazine tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Estradiol 0.5 mg tablets because they may have been mislabeled as Nicotine Polacrilex gum.
Aidapak Services is recalling carbamazepine ER tablets that may be mislabeled as isosorbide dinitrate or sirolimus.
Hospira is recalling 126,425 vials of Propofol Injectable Emulsion due to a glass defect that could release particulate matter into the solution.
Aidapak Services is recalling Losartan Potassium 25 mg tablets because they may have been mislabeled as Phytonadione 5 mg.
Aidapak Services is recalling Phenobarbital tablets that may be mislabeled as Pregabalin capsules. The error poses a risk of patients receiving the wrong medication.
Aidapak Services is recalling Tri-Buffered Aspirin tablets because they may have been mislabeled as a different medication. The error involves a potential mix-up with Isometheptene Mucate/Dichlorphenazone/APAP capsules.
Aidapak Services, LLC is recalling Doxycycline Hyclate 100 mg capsules because they may have been mislabeled as Raloxifene HCL 60 mg tablets.
Aidapak Services, LLC is recalling 20 mg Lovastatin tablets because they may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling 10 mg Nortriptyline HCL capsules because they may have been mislabeled as 80 mg Valsartan tablets.
Aidapak Services is recalling 18,282 Cholecalciferol capsules because they may have been mislabeled as other drugs, including Doxycycline and Lamotrigine.
Aidapak Services, LLC is recalling multivitamin tablets that may have been mislabeled as sitagliptin or loratadine. The FDA classifies this as a Class II recall.
Cubist Pharmaceuticals is recalling 179,870 vials of Cubicin (daptomycin for injection) due to the presence of glass particulates.
Aidapak Services, LLC is recalling 5 mg rosuvastatin calcium tablets because they may have been mislabeled as ibuprofen or ascorbic acid.
Aidapak Services, LLC is recalling Buprenorphine HCL SL tablets due to a potential label mixup with other medications.
Aidapak Services is recalling 2.5 mg Bromocriptine Mesylate tablets that may have been mislabeled as 200 mg Caffeine tablets.
Aidapak Services, LLC is recalling Vitamin B Complex tablets that may have been mislabeled as Cinacalcet HCl. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling 493 Acyclovir 200 mg capsules because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling 81 mg Aspirin DR EC tablets because they may have been mislabeled as Sotalol HCl or Folic Acid.